Why Has It Taken So Long to Learn What We Still Don’t Know?

Why has it taken so long to learn what we still don't know?

What we know and what we still need to learn.

Research has changed the conceptualization of the causes and consequences of violence. Yet some questions remain unanswered. Infants and young children have largely been overlooked, and intraethnic and cultural group variations have not been addressed. There is still a need to address macro-level systematic discrimination in the health care system along with the intrapersonal physiological chan...

Diabetes prevention and care: we know what to do, so why aren't we doing it?

Imagine having such poor vision that you have to rely on your toddler to ‘tell mummy when the big red bus comes’. This patient had had diabetes for most of her life and it had damaged most of her body. I felt sad but I also felt angry. How could this have happened? Of course, diabetes care cannot prevent complications in every patient, but surely we could prevent much of the tissue damage that ...

Molecular approaches to diagnosis of invasive aspergillosis what we know and what we do not know.

Invasive aspergillosis (IA) are a major complication in immunocompromized patients where can be serious and rapidly fatal. Early diagnosis and early appropriate antifungal treatment is important in reducing mortality and morbidity. But despite many efforts to develop detection methods, the diagnosis of IA still remains challenging and current conventional methods are limited for adequate diagno...

Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn …

L ipoprotein(a) (Lp[a]) has been identified as an independent , causal risk factor for cardiovascular disease (CVD). 1,2 Lp(a) has a structure similar to low-density lipopro-tein (LDL) in its lipid core composition in addition to a molecule of apolipoprotein B 100 (apoB), but also contains a unique glycoprotein—apo(a), with strong structural homology with plasminogen. 2 Apo(a) contains anything...